Alkagesta took part in the Commodities Innovation Awards 2026 in Geneva as a Bronze sponsor, according to an account published by Alkagesta Media. The company said representatives from its board and executive team attended the event, which brought together participants from the commodities trading industry to recognise innovation and achievement. Its account presented the sponsorship as part of its engagement with the Swiss commodities community.
The awards were jointly created by Ampersand World and Swiss business magazine Bilan. They focus on the Swiss commodities sector, recognising innovations and approaches intended to help address challenges facing the global economy. According to Alkagesta Media, the 2026 programme covered seven categories: technological innovation, finance innovation, market and trading innovation, sustainability innovation, shipping innovation, supply chain and logistics innovation, and a special jury award. A Personality of the Year Award was also included in the programme.
Geneva is home to Alkagesta’s biofuels and chartering desks and forms a central part of its European operations, the company said. It linked its decision to support the awards to the view that commodities businesses need innovation, collaboration and institutional relationships to navigate geopolitical disruption, pressures associated with the energy transition and increasingly complex supply chains. The account described industry gatherings as a means of fostering those connections, rather than announcing a specific commercial agreement arising from the event.
Alkagesta Media also said the company had been entering additional commodity areas during 2026, expanding sustainable fuels infrastructure and strengthening its presence in European and Asian markets. It did not identify those additional commodity areas or give investment figures, infrastructure locations or expansion targets. Against that backdrop, the company characterised the Swiss commodities network as a base for professional relationships and partnerships supporting its longer-term growth.
Read the original announcement on Alkagesta.